The gradual dose escalation schedule is specifically designed to minimize these symptoms
Warnings and Precautions: Use caution when administering L-Carnitine Injection to patients with renal impairment, as accumulation of carnitine may occur
specifically looked at papilledema and visual disturbance risks [29]
Signs that suggest possible contamination include cloudiness, visible particulates, color change, or unusual odor, but absence of these signs does not confirm sterility
China Anti-obesity Drugs Market The anti-obesity drugs market in China, which was estimated to be USD 1.93 billion in 2025, is growing due to rapid domestic production of lower-cost GLP-1 biosimilars, increasing obesity-linked diabetes burden among urban populations, and strong government focus on chronic metabolic disease management